Location, timing, and size of the European outbreaks. by Albertus Constantijn Sloof (20405090)

Subjects:

Overview of the parameters used in the model. by Albertus Constantijn Sloof (20405090)

Subjects:

SEIR model structure for humans and mosquitoes. by Albertus Constantijn Sloof (20405090)

Subjects:

Coverage curve scenario analysis showing the number of infections at various vaccination coverage rates. by Albertus Constantijn Sloof (20405090)

Subjects:

Parameters used for calibration to anzio and transfer to Rome. by Albertus Constantijn Sloof (20405090)

Subjects:

Interpretation of parameters determining infection development and transmission. by Albertus Constantijn Sloof (20405090)

Subjects:

LC/MS/MS results for vitamin D analysis. by Jessica S. Brown (15021996)

Subjects:

Process for the gamma irradiation, extraction, and analysis of vitamin D in finfish. by Jessica S. Brown (15021996)

Subjects:

Mortality rates per lifecycle stage [28]. by Albertus Constantijn Sloof (20405090)

Subjects:

The effect of irradiation on the percent recovery of vitamin D in salmon (left) and trout (right) fillets in the frozen state. by Jessica S. Brown (15021996)

Subjects:

Tornado diagram showing the results of a one-way sensitivity analysis conducted for the scenario with vaccination. by Albertus Constantijn Sloof (20405090)

Subjects:

Tornado diagram showing the results of a one-way sensitivity analysis conducted for the scenario without vaccination. by Albertus Constantijn Sloof (20405090)

Subjects:

Duration of development between lifecycle stage of mosquitoes [28]. by Albertus Constantijn Sloof (20405090)

Subjects:

The effect of irradiation on the percent recovery of vitamin D in salmon (left) and trout (right) fillets in the chilled state. by Jessica S. Brown (15021996)

Subjects:

Raw temperature series and polynomial smoothing curves, Rome. by Albertus Constantijn Sloof (20405090)

Subjects:

CKO mice display decreased skin barrier function and perturbed homeostasis. by Kevin J. Mills (9270966)

Subjects:

Changes in the liver fibrosis-related markers in breast cancer patients with a FIB-4 index of >2.30 during letrozole treatment. by Kazuyoshi Ohkawa (836847)

Subjects:

Changes in the FIB-4 index in breast cancer patients with a FIB-4 index of ≥ 2.67 during letrozole and anastrozole treatment. by Kazuyoshi Ohkawa (836847)

Subjects:

Changes in the liver fibrosis-related markers in breast cancer patients with a FIB-4 index of >2.30 during anastrozole treatment. by Kazuyoshi Ohkawa (836847)

Subjects:

Estimated average absolute and relative changes in energy (kcal/capita/day) from the no-policy counterfactual by phase, high-in status, and SES. by Lindsey Smith Taillie (3159258)

Subjects: